Purchase Order 36C24124P0784
Award Date
8/19/24
Potential Completion Date
9/30/25
Potential Value
$210K
Federal Agency
Veterans Integrated Service Network 1
Awardee
Sofie CO.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West Haven, CT 06516, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $29,200 firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of the radiopharmaceutical NEURACEQ (florbetaben F-18) to support medical imaging services at VA facilities. The contract is part of a larger Indefinite Delivery Vehicle (IDV) held by Sofie with the VA, which facilitates the ongoing procurement of specialized radiopharmaceuticals and related services....
This is a $47,925 firm-fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Sofie CO., doing business as IBA Molecular, for the supply of NEURACEQ (florbetaben F-18), a diagnostic radiotracer used for Alzheimer's patient PET imaging. The contract has a period of performance through February 11, 2026, and was awarded on February 12, 2025 without a set-aside designation. Sofie CO. is a for-profit organization that specializes in the development and...
This is a firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of Neuraceq Florbetaben F-18 Injections. The contract has a ceiling value of $427,500.00 and runs through September 30, 2024. The award was made without a set-aside designation, reflecting Sofie's established position as a specialized supplier of radiopharmaceuticals and related services to the VA. Sofie Biosciences, Inc. has extensive...
This federal contract award was issued by the Defense Health Agency (DHA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of Neuraceq (florbetaben F-18), a nuclear medicine PET imaging agent used to estimate amyloid neuritic plaque density in adult patients at the Walter Reed National Military Medical Center. The $17,500.00 firm-fixed-price purchase order does not have a set-aside designation. Sofie Biosciences is a specialized manufacturer and supplier of molecular...
This is a $1,916,610.00 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of FDG and NEURACEQ radiopharmaceuticals, which are critical medical imaging products used for cancer detection and Alzheimer's disease diagnostics. Sofie Biosciences, Inc. is a specialized manufacturer of molecular diagnostics and therapeutics, with a...
This federal contract award is for the delivery of radiopharmaceuticals and related services to the Department of Veterans Affairs (VA). The prime contractor, Sofie CO., is a subsidiary of Sofie Biosciences, Inc., a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with a focus on radiopharmaceuticals. The contract has a ceiling value of $90,125.00 and is a firm-fixed-price delivery order, with an ultimate completion date of September 30, 2020. The contract is...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $195,650 firm fixed price purchase order to Sofie CO doing business as Sofie. The contract is for the provision of NEURACEQ AMYLOID imaging agent doses to the Cleveland VA Medical Center from October 1, 2023 through September 30, 2024. The original solicitation sought capabilities statements for the competitive procurement of Axumin, Amyvid, and Cerianna radiopharmaceutical doses...
This federal contract award is for the provision of radiopharmaceuticals, specifically fluorodeoxyglucose (F-18 FDG), to the Department of Veterans Affairs (VA). The contract was awarded to Sofie CO., a subsidiary of Sofie Biosciences, Inc., which specializes in the development and supply of molecular diagnostics and radiopharmaceuticals, including products for prostate cancer detection and Alzheimer's disease imaging. The contract, valued at $1,828,575.00, is a definitive, firm-fixed-price...
This federal contract award is for a Blanket Purchase Agreement (BPA) call with the Veterans Integrated Service Network 15 (VISN 15) of the Department of Veterans Affairs (VA). The contract, valued at $430,370.45, is for the delivery of radiopharmaceuticals and related products and services. The prime contractor is Sofie CO., a subsidiary of Sofie Biosciences, Inc., which specializes in the development and supply of molecular diagnostics and therapeutics, including radiopharmaceuticals for...
This is a $730,800 firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of Amyloid Florbetaben Injections, a radiopharmaceutical product, to the VA Healthcare System. The award is not set aside and is a follow-on to a previous sole source contract issued by the VA's Network Contracting Office (NCO) 8 to Sofie for the supply of Neuraceq Florbetaben F-18...